DENISE CUSICK: Open Payments
NPI 1356894414 · SUCCASUNNA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 21 payments from 12 companies in 2025. Trend: 2023 $336 · 2024 $304 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| Lilly USA, LLC | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Amgen Inc. | 2 | $34 |
| Novo Nordisk Inc | 2 | $33 |
| Dexcom, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
Products named: Kerendia, MOUNJARO, BREZTRI, Dexcom G6 Transmitter, REXULTI, REPATHA, WELLBUTRIN, TRELEGY ELLIPTA.
Industry payments across NJ — which companies pay providers there.
